4//SEC Filing
Haas Jason 4
Accession 0002001011-24-000057
CIK 0000886163other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 9:26 PM ET
Size
7.3 KB
Accession
0002001011-24-000057
Insider Transaction Report
Form 4
Haas Jason
Director
Transactions
- Award
Common Stock
2024-06-14+1,252→ 5,397 total - Award
Non-Qualified Stock Option (right to buy)
2024-06-14+5,444→ 5,444 totalExercise: $80.06Exp: 2034-06-14→ Common Stock (5,444 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
- [F2]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001883821
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 9:26 PM ET
- Size
- 7.3 KB